دورية أكاديمية

Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats.

التفاصيل البيبلوغرافية
العنوان: Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats.
المؤلفون: Kodama T; Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori, Japan., Otani K; Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori, Japan., Okada M; Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori, Japan., Yamawaki H; Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori, Japan.
المصدر: The Journal of veterinary medical science [J Vet Med Sci] 2023 Dec 19; Vol. 85 (12), pp. 1314-1318. Date of Electronic Publication: 2023 Oct 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Japanese Society Of Veterinary Science Country of Publication: Japan NLM ID: 9105360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1347-7439 (Electronic) Linking ISSN: 09167250 NLM ISO Abbreviation: J Vet Med Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Tokyo : Japanese Society Of Veterinary Science
مواضيع طبية MeSH: Elongation Factor 2 Kinase*/antagonists & inhibitors , Nitric Oxide*, Animals ; Rats ; Blood Pressure ; Diuresis ; Diuretics/pharmacology ; Enzyme Inhibitors/pharmacology ; NF-E2-Related Factor 2/metabolism ; Pyrimidines/pharmacology ; Rats, Inbred SHR
مستخلص: Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) is a protein kinase that inactivates eEF2, a protein that mediates a peptidyl-tRNA translocation during an elongation step of protein synthesis. We have previously shown that eEF2K was involved in pathogenesis of essential and pulmonary hypertension. A484954 (7-amino-1-cyclopropyl-3-ethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carboxamide), a selective eEF2K inhibitor, is a membrane permeable small molecule. We have previously shown that A484954 lowered blood pressure and induced diuretic effects in spontaneously hypertensive rats (SHR) due to an increase in renal blood flow. Here we aimed to reveal mechanisms underlying the diuretic effects of A484954 in SHR. A484954-induced diuresis and increase in urinary Na + excretion were inhibited by N (G)-nitro-L-arginine methyl ester (L-NAME), a nitric oxide (NO) synthase inhibitor. A484954 increased mRNA expression of angiotensin type 2 receptor (AT2R) and nuclear factor-erythroid 2-related factor 2 (Nrf2). In summary, we for the first time revealed that A484954 induces diuresis in SHR at least partly via the activation of NO/Nrf2/AT2R pathway.
References: Int J Mol Sci. 2022 Feb 19;23(4):. (PMID: 35216442)
Am J Physiol Renal Physiol. 2006 Jun;290(6):F1430-6. (PMID: 16380464)
Eur J Biochem. 1993 Apr 15;213(2):689-99. (PMID: 8386634)
Electrolyte Blood Press. 2008 Jun;6(1):27-34. (PMID: 24459519)
J Pharmacol Sci. 2020 Nov;144(3):165-171. (PMID: 32811745)
Am J Physiol Heart Circ Physiol. 2015 May 15;308(10):H1298-305. (PMID: 25770246)
FEBS Lett. 1991 May 6;282(2):253-8. (PMID: 2037042)
Biochem Biophys Res Commun. 2011 Feb 4;405(1):47-51. (PMID: 21195054)
J Biol Chem. 1987 Dec 25;262(36):17299-303. (PMID: 3693353)
Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H756-68. (PMID: 23812389)
J Pharmacol Sci. 2018 May;137(1):86-92. (PMID: 29778449)
J Biol Chem. 2011 Dec 23;286(51):43951-43958. (PMID: 22020937)
Proc Natl Acad Sci U S A. 1997 May 13;94(10):4884-9. (PMID: 9144159)
Circ Res. 2020 Feb 28;126(5):644-659. (PMID: 31997705)
Hypertension. 2017 Oct;70(4):831-838. (PMID: 28827476)
J Vet Med Sci. 2019 Oct 24;81(10):1509-1514. (PMID: 31484844)
Eur J Pharmacol. 2021 Dec 15;913:174637. (PMID: 34801528)
Expert Rev Cardiovasc Ther. 2010 Jun;8(6):793-802. (PMID: 20528637)
Cardiovasc Res. 2007 Jul 15;75(2):261-74. (PMID: 17498676)
J Physiol Pharmacol. 2018 Apr;69(2):. (PMID: 29980143)
Circ Res. 2014 Jul 18;115(3):388-99. (PMID: 24903104)
فهرسة مساهمة: Keywords: A484954; diuretic effect; eukaryotic elongation factor 2 kinase; nitric oxide
المشرفين على المادة: 0 (A-484954)
0 (Diuretics)
EC 2.7.11.20 (Elongation Factor 2 Kinase)
0 (Enzyme Inhibitors)
0 (NF-E2-Related Factor 2)
31C4KY9ESH (Nitric Oxide)
0 (Pyrimidines)
تواريخ الأحداث: Date Created: 20231019 Date Completed: 20240105 Latest Revision: 20240319
رمز التحديث: 20240319
مُعرف محوري في PubMed: PMC10788169
DOI: 10.1292/jvms.23-0306
PMID: 37853639
قاعدة البيانات: MEDLINE
الوصف
تدمد:1347-7439
DOI:10.1292/jvms.23-0306